Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqCM:ZENA
NasdaqCM:ZENASoftware

A Look At ZenaTech (ZENA) Valuation As New Seoul And London Offices Expand Its Global Reach

Why ZenaTech’s latest expansion is on investors’ radar ZenaTech (ZENA) is drawing attention after opening new offices in Seoul and London. These moves are aimed at supporting its ZenaDrone, Drone as a Service, and enterprise SaaS operations across APAC and EMEA. See our latest analysis for ZenaTech. At a share price of $2.24, ZenaTech has seen a 9.27% 1 day share price return and 5.66% 7 day share price return, but a 55.47% 90 day share price decline. Its 1 year total shareholder return of...
SGX:DCRU
SGX:DCRUSpecialized REITs

Digital Core REIT (SGX:DCRU) Q1 2026 Revenue Softness Reinforces Bearish Narratives

Digital Core REIT (SGX:DCRU) reported Q1 2026 revenue of US$44.1 million and basic EPS of US$0.004, setting a cautious tone for investors tracking its latest update. Over recent periods, revenue has moved between US$39.8 million in Q4 2024 and US$63.1 million in Q3 2025, while basic EPS has ranged from US$0.139 in Q4 2024 to US$0.022 in Q4 2025, providing a mixed picture of earnings power across the last few quarters. With trailing 12 month profit margins at 26.2% and a large one off gain...
NasdaqGS:GEHC
NasdaqGS:GEHCMedical Equipment

GE HealthCare’s Manganese MRI Trial Adds New Contrast And Revenue Potential

GE HealthCare Technologies (NasdaqGS:GEHC) has dosed the first patient in its Phase 2/3 LUMINA trial for mangaciclanol, a manganese based MRI contrast agent. The agent holds FDA Fast Track designation and is being studied as a potential alternative to gadolinium based contrast agents. The company highlights potential benefits related to patient safety, supply reliability, and reduced reliance on rare earth elements. GE HealthCare enters this trial with its shares at $71.38 and a mixed...
NasdaqCM:FFAI
NasdaqCM:FFAIAuto

A Look At Faraday Future (FFAI) Valuation After Triple I Embodied AI Education Partnership

Triple I partnership brings Faraday Future’s AI robotics into classrooms Faraday Future Intelligent Electric (FFAI) has drawn fresh attention after partnering with education institution Triple I to launch an Embodied AI robotics summer camp and broader EAI education programs in Irvine, California. This education focused move links the company’s EAI robots directly with K 12 students, parents, and teachers, giving investors a clearer view of how Faraday Future aims to apply its robotics...
NasdaqGS:BIIB
NasdaqGS:BIIBBiotechs

Biogen Gains China Felzartamab Rights As Valuation Gap Draws Attention

Biogen (NasdaqGS:BIIB) has acquired exclusive rights to felzartamab in the Greater China Region from TJ Biopharma. The deal consolidates global rights to felzartamab, an antibody in Phase 3 trials for multiple immune mediated diseases. Biogen will lead development and commercialization of felzartamab in Greater China, a key market for conditions such as IgAN and PMN. For investors tracking Biogen, this move adds a late stage immunology asset to a pipeline already focused on serious...
NasdaqGS:XEL
NasdaqGS:XELElectric Utilities

Is It Time To Reassess Xcel Energy (XEL) After Recent Grid Investment Focus?

If you are wondering whether Xcel Energy’s share price still reflects fair value or if the market is overlooking something, this article breaks down what the current price might be telling you. The stock last closed at US$78.11, with returns of 1.5% over 30 days and 12.6% over the past year. This may signal that market expectations and perceived risk have shifted over time. Recent attention on utilities, energy infrastructure and the broader power grid has kept Xcel Energy on many investors’...
NYSE:AIN
NYSE:AINMachinery

Is Albany International (AIN) Offering Value After A 9.6% Monthly Share Price Gain?

Wondering if Albany International at around US$55.77 is a bargain or a value trap? This article breaks down what the current share price might actually be offering you. The stock is up 9.6% over the past month and 6.6% year to date, but still shows a 1.5% slip over 7 days and a 9.6% decline over the past year. Recent coverage has focused on Albany International's share price performance and how longer term returns over 3 and 5 years compare to more recent moves. This helps frame whether the...
NasdaqGS:EXTR
NasdaqGS:EXTRCommunications

Extreme Networks Platform ONE Adoption Highlights AI Automation And Cost Focus

Extreme Networks announced major new customer adoption for its Extreme Platform ONE offering, highlighting expanding real world usage of its AI driven networking capabilities. The company reported that organizations are using Extreme Platform ONE to automate network operations and reduce costs relative to competing solutions. The update centers on concrete deployments and product advances that had not been previously detailed to investors. Extreme Networks, listed on NasdaqGS:EXTR, is...
TSE:7261
TSE:7261Auto

Mazda’s Indiana Transmission Shift And What It May Mean For Valuation

Aisin has begun contract manufacturing Mazda Motor's six speed automatic transmission in Indiana. The new production is aimed at improving Mazda's transmission supply and responsiveness within North America. This move expands Mazda's manufacturing footprint closer to its key regional customers. Mazda Motor (TSE:7261) is drawing fresh attention with this new North American transmission production, coming at a time when the shares trade at ¥1,058.0. The stock has seen a 30.4% gain over the...
TSE:8060
TSE:8060Electronic

Canon Marketing Japan (TSE:8060) Margin Gain With 6.6% Net Profit Challenges Premium P/E Concerns

Canon Marketing Japan (TSE:8060) has opened Q1 2026 with total revenue of ¥171.7 billion and basic EPS of ¥120.18, setting a clear marker for the new fiscal year. The company has seen revenue move from ¥167.3 billion in Q1 2025 to ¥171.7 billion in Q1 2026, while basic EPS over the same quarters shifted from ¥40.44 to ¥120.18, giving investors a clear view of how the top line and EPS have tracked together as margins have evolved. See our full analysis for Canon Marketing Japan. With the...
NasdaqGS:WSBC
NasdaqGS:WSBCBanks

WesBanco (WSBC) Q1 Net Profit Margin Story Tests Bullish Efficiency Narrative

WesBanco (WSBC) opened 2026 with Q1 revenue of US$258.1 million and net income of US$84.4 million, translating to EPS of US$0.88, set against a trailing 12 month EPS of US$3.12 on revenue of US$1.04 billion. Over recent periods, revenue has ranged from US$123.4 million in Q1 2025 to around US$262.5 million in Q4 2025, while quarterly EPS moved from a loss of US$0.15 in Q1 2025 to US$0.81 in Q4 2025 and US$0.88 in the latest quarter. This gives investors a clearer earnings run-rate to assess...
NasdaqCM:ORRF
NasdaqCM:ORRFBanks

Orrstown Financial Services (ORRF) Net Margin Surge Reinforces Bullish Profitability Narrative

Orrstown Financial Services (ORRF) opened 2026 with Q1 revenue of US$64.2 million and basic EPS of US$1.13, supported by quarterly net income of US$21.8 million and a trailing twelve month EPS of US$4.40 that sits against a 168% year over year earnings lift and a net profit margin of 33.1% versus 15.5% a year earlier. Over the past year, revenue on a trailing basis has moved from US$176.1 million in Q4 2024 to US$255.4 million in Q1 2026, while quarterly EPS has ranged from US$0.72 in Q4 2024...
NYSE:BLD
NYSE:BLDConsumer Durables

QXO To Acquire TopBuild And Recast Shareholder Upside In Sector Giant

QXO has reached a definitive agreement to acquire TopBuild, bringing together two large players in North American building products distribution. The combined company is set to become the second largest publicly traded building products distributor in North America. The deal is expected to immediately affect earnings and widen QXO’s addressable market, operational scale, and presence across the region. For TopBuild (NYSE:BLD), the news comes after a period of strong share price performance,...
NYSE:Q
NYSE:QSemiconductor

A Look At Qnity Electronics (Q) Valuation After Strong Recent Share Price Gains

Qnity Electronics stock moves after recent gains Qnity Electronics (Q) is drawing fresh attention after a recent share price move, with the stock up 3.3% on the day and showing double digit returns over the past month and past 3 months. See our latest analysis for Qnity Electronics. The recent 3.3% one day share price return and 21.2% 30 day share price return sit within a stronger trend, with the year to date share price return of 63.9% pointing to building momentum rather than a short term...
NYSE:CB
NYSE:CBInsurance

Chubb (CB) Q1 Combined Ratio Of 84% Tests Bullish Underwriting Narrative

Q1 2026 results set the stage for a mixed narrative Chubb (CB) has kicked off Q1 2026 with total revenue of US$14.8 billion and basic EPS of US$5.88, supported by net income of US$2.32 billion and a combined ratio of 84% in its insurance operations. Over the past year, the company has seen total revenue move from US$13.4 billion in Q1 2025 to US$14.8 billion in Q1 2026, while trailing twelve month basic EPS shifted from US$21.00 at Q1 2025 to US$28.60 at Q1 2026. This is setting up a results...
NasdaqGS:ODFL
NasdaqGS:ODFLTransportation

Is It Too Late To Consider Buying Old Dominion Freight Line (ODFL) After Strong Share Gains?

Wondering whether Old Dominion Freight Line at around US$219.98 is offering value or asking you to pay a premium? This article walks through what the current price might be telling you. The stock has recorded returns of 7.2% over the last 7 days, 17.2% over the last 30 days, 38.2% year to date and 44.6% over the past year, with a 3 year return of 46.5% and a 5 year return of 75.3%. Recent headlines around Old Dominion Freight Line have focused on its role in the US transportation sector and...
NasdaqCM:AHCO
NasdaqCM:AHCOHealthcare

AdaptHealth Credit Upgrade And New US$1.1b Facility Reshape Outlook

AdaptHealth (NasdaqCM:AHCO) has closed a new US$1.1b senior secured credit facility with improved terms. The facility follows recent upgrades in the company’s credit ratings and adjusts key elements of its capital structure. The refinancing affects borrowing costs, debt maturities, and available credit for AdaptHealth’s operations. AdaptHealth provides home medical equipment and related services, a segment tied to ongoing demand for at home care solutions. For investors watching the broader...
TSX:VNP
TSX:VNPChemicals

3 TSX Stocks That May Be Trading Below Their Estimated Value

As the Canadian market navigates a complex landscape marked by uncertainty around energy supply disruptions and economic surveys, investors are keenly observing how these factors might influence stock valuations. In such an environment, identifying stocks that may be trading below their estimated value can offer potential opportunities for those looking to balance growth with value in their portfolios.